Okay, let's tackle this question about tumor suppressor genes. First, I need to recall the basic difference between oncogenes and tumor suppressor genes. Oncogenes are mutated forms of proto-oncogenes that drive cell proliferation, while tumor suppressor genes normally inhibit cell division and promote apoptosis.

The question is asking for an example of a tumor suppressor gene. Common examples include TP53, BRCA1, BRCA2, RB1, APC, and others. These genes are involved in DNA repair, cell cycle regulation, and apoptosis. For instance, TP53 (p53) is crucial for stopping the cell cycle when DNA is damaged. Mutations in TP53 are found in many cancers. BRCA1 and BRCA2 are involved in DNA repair and their mutations increase the risk of breast and ovarian cancers. RB1 is associated with retinoblastoma.

Now, looking at the options, the correct answer should be one of these. Let's say the options were A. TP53, B. RAS, C. MYC, D. HER2. In that case, the correct answer would be A. TP53. RAS, MYC, and HER2 are oncogenes, so they are not tumor suppressor genes.

The incorrect options are oncogenes because they promote cancer when mutated. The clinical pearl here is to remember that tumor suppressor genes are often named after the diseases they cause when mutated, like BRCA for breast cancer or RB for retinoblastoma. Also, p53 is known as the "guardian of the genome" because of its role in DNA repair and apoptosis.

**Core Concept**
Tumor suppressor genes encode proteins that regulate cell cycle progression, DNA repair, and apoptosis. Loss-of-function mutations in these genes remove critical safeguards against uncontrolled cell proliferation, a hallmark of cancer. Key examples include *TP53*, *BRCA1*, *BRCA2*, and *RB1*.

**Why the Correct Answer is Right**
**TP53** (encoded by the *TP53* gene) is a classic tumor suppressor gene. Its protein product, p53, acts as a transcription factor that activates DNA repair pathways or induces apoptosis in response to DNA damage. Mutations in *TP53* are found in ~50% of all human cancers, highlighting its central role in preventing malignant transformation.

**Why Each Wrong Option is Incorrect**
**Option A:** *RAS* is an oncogene; gain-of-function mutations in *KRAS*, *HRAS*, or *NRAS* drive uncontrolled cell growth.
**Option B:** *MYC* is another oncogene; overexpression promotes cell cycle progression and is linked to aggressive cancers like Burkitt’s lymphoma.
**Option C:** *HER2* (ERBB2) is an oncogene amplified in ~20% of breast cancers, leading to hyperactivation of growth signaling.

**Clinical Pearl / High-Yield Fact**
Remember the "2 P’s" of tumor suppressor genes: **P**53 (*TP53*) and **P**16 (*CDKN2A*). These are among the most frequently mutated tumor suppressors. Contrast with oncogenes like *RAS*, *MYC*, and *HER2*, which

✓ Correct Answer: D. RB